Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.
#50 - Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation
Join us on the latest episode! Our Guest: Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation.
What you'll get out of this episode:
PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid nanoparticle-based immunotherapy.
Their lead candidate, PDS0101, demonstrated over 2x improvement in survival for HPV-positive head and neck cancer.
The platform technology shows consistent efficacy across multiple independent Phase 2 trials.
Late-stage clinical programs focus on HPV16+ head and neck cancer, with additional trials for colorectal, prostate, and MUC1+ cancers.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/frank-bedu-addo-4797947/ (https://www.linkedin.com/in/frank-bedu-addo-4797947/)
Company LinkedIn https://www.linkedin.com/company/pds-biotechnology-corporation/ (https://www.linkedin.com/company/pds-biotechnology-corporation/)
Website https://www.pdsbiotech.com/ (https://www.pdsbiotech.com/)
(https://www.curraxpharma.com/)
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/ (https://sage-growth.com/)
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ (https://www.linkedin.com/company/sliceofhealthcare/)
27 May 2025
#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories
Michael Demurjian, Founder & CEO at Aspargo Laboratories, discusses Aspargo's innovative oral suspensions that improve drug absorption through buccal and GI routes, offering rapid treatment, in this interview.
15 Apr 2025
#48 - Michael Oleksiw, CEO at Pleio
Host [Host Name] interviews Michael Oleksiw, CEO at Pleio, about how emotionally aware AI and peer support improve medication adherence by addressing emotional barriers.
Who has been a guest on BioBreakthroughs
Names identified in recent episode analyses. Showing up to five guests.
Michael Demurjian
Michael Oleksiw
Bill Peters
Frank Watanabe
Aaron Mackey
Contact BioBreakthroughs
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of BioBreakthroughs?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
